The estimated Net Worth of Kent Cjayhawk Capital Manag... is at least $29.9 Million dollars as of 17 November 2014. Kent Manag owns over 26,754 units of Global Cord Blood Corp stock worth over $29,917,665 and over the last 10 years Kent sold CO stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kent Manag CO stock SEC Form 4 insiders trading
Kent has made over 1 trades of the Global Cord Blood Corp stock since 2014, according to the Form 4 filled with the SEC. Most recently Kent bought 26,754 units of CO stock worth $125,744 on 17 November 2014.
The largest trade Kent's ever made was buying 26,754 units of Global Cord Blood Corp stock on 17 November 2014 worth over $125,744. On average, Kent trades about 26,754 units every 0 days since 2014. As of 17 November 2014 Kent still owns at least 10,013,946 units of Global Cord Blood Corp stock.
You can see the complete history of Kent Manag stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Global Cord Blood Corp
Over the last 10 years, insiders at Global Cord Blood Corp have traded over $0 worth of Global Cord Blood Corp stock and bought 176,754 units worth $899,744 . The most active insiders traders include Kent Cjayhawk Capital Manag... and Kent Cjayhawk Capital Manag.... On average, Global Cord Blood Corp executives and independent directors trade stock every 7 days with the average trade being worth of $264,035. The most recent stock trade was executed by Kent Cjayhawk Capital Manag... on 17 November 2014, trading 26,754 units of CO stock currently worth $125,744.
What does Global Cord Blood Corp do?
china cord blood corp (6cb) is a hospital and health care company located in 1 garden road, hong kong, hong kong island, hong kong.
What does Global Cord Blood Corp's logo look like?
Complete history of Kent Manag stock trades at Global Cord Blood Corp
Global Cord Blood Corp executives and stock owners
Global Cord Blood Corp executives and other stock owners filed with the SEC include:
-
Ting Zheng,
Chairman of the Board, Chief Executive Officer and Chief Executive Officer - Beijing -
Albert Chen,
Chief Financial Officer, Director -
Bing Chuen Chen,
CFO & Director -
Ting Zheng,
Chairperson , CEO & CEO of Beijing Division -
Rui Arashiyama,
Chief Executive Officer - Guangdong and Zhejiang Divisions -
Rui Arashiyama,
Chief Exec. Officer of Guangdong & Zhejiang Divisions -
Xin Xu,
Chief Technology Officer -
Xin Xu,
Chief Technology Officer -
Jennifer Weng,
Independent Non-Executive Director -
Ken Lu,
Independent Non-Executive Director -
Jack Chow,
Independent Non-executive Director -
Siu Chuen Cheng,
Independent Non-executive Director -
Mark Chen,
Independent Non-Executive Director -
Ping Xu,
Non-Executive Director -
Cathy Bai,
VP of Corp. Fin. -
Kent Cjayhawk Capital Manag...,
-
Kent Cjayhawk Capital Manag...,